Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025)
Arcellx's (ACLX) quarterly Other Non-Current Liabilities came in at $3.4 million in Q1 2025, down 77.78% year-on-year from $15.5 million in Q1 2024, and down 60.0% quarter-over-quarter from $8.6 million in Q4 2024.
Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends
Arcellx's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 77.78% year-over-year to $3.4 million in Q1 2025; TTM through Mar 2025 was $3.4 million, a 77.78% decrease from a year earlier, with the FY2024 full-year figure at $8.6 million, changed N/A from the prior year.
- Other Non-Current Liabilities eased to $3.4 million in Q1 2025 per ACLX's latest filing, from $8.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $15.5 million in Q1 2024 and bottomed at $117000.0 in Q2 2022.
- The 4-year median for Other Non-Current Liabilities is $6.0 million (2024), against an average of $7.2 million.
- Biggest YoY gain for Other Non-Current Liabilities was 77.78% in 2025; the steepest drop was 77.78% in 2025.
- Year by year, Other Non-Current Liabilities stood at $178000.0 in 2021, then plunged by 34.27% to $117000.0 in 2022, then soared by 7244.44% to $8.6 million in 2024, then sank by 60.0% to $3.4 million in 2025.
- Per Business Quant, the three latest ACLX Other Non-Current Liabilities figures stand at $3.4 million (Q1 2025), $8.6 million (Q4 2024), and $15.0 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 8.59 Mn |
| Sep 30, 2024 | 15.05 Mn |
| Jun 30, 2024 | 14.90 Mn |
| Mar 31, 2024 | 15.47 Mn |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 178,000.00 |